Non‐invasive cell‐free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China

To analyze the non‐invasive prenatal testing (NIPT) for aneuploidy results of 31 515 singleton pregnancies in Fujian province, southeastern China, and assess its performance in low‐, moderate‐ and high‐risk pregnancies.

[1]  F. Yu,et al.  Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes , 2019, Genetics in Medicine.

[2]  B. Levy,et al.  Traditional Prenatal Diagnosis: Past to Present. , 2018, Methods in molecular biology.

[3]  L. Hui Noninvasive Approaches to Prenatal Diagnosis: Historical Perspective and Future Directions. , 2018, Methods in molecular biology.

[4]  S. Phelan,et al.  Delivering the Diagnosis of Sex Chromosome Aneuploidy: Experiences and Preferences of Parents and Individuals , 2018, Clinical pediatrics.

[5]  A. Caughey,et al.  How should costs and cost-effectiveness be considered in prenatal genetic testing? , 2018, Seminars in perinatology.

[6]  Zhengfeng Xu,et al.  Perinatal outcomes following cell‐free DNA screening in >32 000 women: Clinical follow‐up data from a single tertiary center , 2018, Prenatal diagnosis.

[7]  S. Y. Kim,et al.  Prospective observations study protocol to investigate cost-effectiveness of various prenatal test strategies after the introduction of noninvasive prenatal testing , 2018, BMC Pregnancy and Childbirth.

[8]  P. Serrano-Aguilar,et al.  Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review , 2018, The European Journal of Health Economics.

[9]  D. Deng,et al.  New medical risks affecting obstetrics after implementation of the two-child policy in China , 2017, Frontiers of Medicine.

[10]  A. Breman,et al.  Positive predictive value estimates for cell‐free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory , 2017, American journal of obstetrics and gynecology.

[11]  R. Kirby The prevalence of selected major birth defects in the United States. , 2017, Seminars in perinatology.

[12]  M. Plana,et al.  Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysis , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[13]  V. Cirigliano,et al.  Screening for Sex Chromosome Aneuploidy by Cell-Free DNA Testing: Patient Choice and Performance , 2017, Fetal Diagnosis and Therapy.

[14]  N. Vora,et al.  Prenatal Diagnosis: Screening and Diagnostic Tools. , 2017, Obstetrics and gynecology clinics of North America.

[15]  Lorenzo D Botto,et al.  Etiology and clinical presentation of birth defects: population based study , 2017, British Medical Journal.

[16]  P. Opara,et al.  Prevalence and pattern of birth defects in a tertiary health facility in the Niger Delta area of Nigeria , 2017, International journal of women's health.

[17]  E. Bernabé,et al.  Analysis of cell‐free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population – a systematic review and meta‐analysis , 2017, Acta obstetricia et gynecologica Scandinavica.

[18]  R. Morris,et al.  The accuracy of cell‐free fetal DNA‐based non‐invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta‐analysis , 2017, BJOG : an international journal of obstetrics and gynaecology.

[19]  Y. Takwoingi,et al.  Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. , 2015, The Cochrane database of systematic reviews.

[20]  C. Chung,et al.  Clinical Experience of Non-Invasive Prenatal Chromosomal Aneuploidy Testing in 190,277 Patient Samples. , 2016, Current molecular medicine.

[21]  D. Cram,et al.  Copy number variation sequencing‐based prenatal diagnosis using cell‐free fetal DNA in amniotic fluid , 2016, Prenatal diagnosis.

[22]  A. Latos-Bieleńska,et al.  Cell-Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal Sex. , 2016, Clinical chemistry.

[23]  Aileen Clarke,et al.  Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis , 2016, BMJ Open.

[24]  R. Stokowski,et al.  Clinical performance of non‐invasive prenatal testing (NIPT) using targeted cell‐free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies , 2015, Prenatal diagnosis.

[25]  L. Dugoff,et al.  Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis , 2015, Prenatal diagnosis.

[26]  J. Hornberger,et al.  An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population , 2015, PloS one.

[27]  Y. Gao,et al.  Non‐invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnancies , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[28]  T. Musci,et al.  Cell-free DNA analysis for noninvasive examination of trisomy. , 2015, The New England journal of medicine.

[29]  E. Hardisty,et al.  Advances in genetic prenatal diagnosis and screening , 2014, Current opinion in pediatrics.

[30]  S. Carmichael Birth defects epidemiology. , 2014, European journal of medical genetics.

[31]  R. Rava,et al.  DNA sequencing versus standard prenatal aneuploidy screening. , 2014, The New England journal of medicine.

[32]  M. Rochon DNA Sequencing Versus Standard Prenatal Aneuploidy Screening , 2014 .

[33]  Yijun Song,et al.  Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population , 2013, Prenatal diagnosis.

[34]  D. Liang,et al.  Non‐invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing , 2013, Prenatal diagnosis.

[35]  X. Bian,et al.  Current situation and development of prenatal diagnosis in China , 2010, Frontiers of medicine in China.

[36]  Yingyao Chen,et al.  Situation analysis of prenatal diagnosis technology utilization in China: Current situation, main issues, and policy implications , 2004, International Journal of Technology Assessment in Health Care.

[37]  I. Sargent,et al.  Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.